Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (21-30 of 492) with videos related to

Pageof 50
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 15, 2014
Molecular alterations and emerging targets in castration resistant prostate cancerD Lorente, J S De Bono
Expert Opinion on Investigational Drugs|November 4, 2011
Belinostat: clinical applications in solid tumors and lymphomaL Rhoda Molife, Johann S de Bono
British Medical Bulletin|November 8, 2002
Therapeutics targeting signal transduction for patients with colorectal carcinomaJohann S de Bono, Eric K Rowinsky
Therapeutic Advances in Medical Oncology|December 1, 2011
c-MET: an exciting new target for anticancer therapyJohann S de Bono, Timothy A Yap
Investigational New Drugs|April 9, 2001
The oral fluorinated pyrimidinesJ S de Bono, C J Twelves
Therapeutic Advances in Medical Oncology|December 1, 2011
Future directions in the evaluation of c-MET-driven malignanciesJohann S de Bono, Timothy A Yap
Trends in Molecular Medicine|April 3, 2002
The ErbB receptor family: a therapeutic target for cancerJohann S de Bono, Eric K Rowinsky
Molecular Cancer Therapeutics|May 6, 2010
Targeting the HGF/c-Met axis: state of playTimothy A Yap, Johann S de Bono
European Urology|April 8, 2019
PARP Inhibitors for Advanced Prostate Cancer: Validating Predictive BiomarkersJoaquin Mateo, Suzanne Carreira, Johann S de Bono
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathwayGerhardt Attard, Juliet Richards, Johann S de Bono
Pageof 50

Showing results (21-30 of 492) with videos related to

Sort By:
Pageof 50
European Journal of Cancer (Oxford, England : 1990)|January 15, 2014
Molecular alterations and emerging targets in castration resistant prostate cancerD Lorente, J S De Bono
Expert Opinion on Investigational Drugs|November 4, 2011
Belinostat: clinical applications in solid tumors and lymphomaL Rhoda Molife, Johann S de Bono
British Medical Bulletin|November 8, 2002
Therapeutics targeting signal transduction for patients with colorectal carcinomaJohann S de Bono, Eric K Rowinsky
Therapeutic Advances in Medical Oncology|December 1, 2011
c-MET: an exciting new target for anticancer therapyJohann S de Bono, Timothy A Yap
Investigational New Drugs|April 9, 2001
The oral fluorinated pyrimidinesJ S de Bono, C J Twelves
Therapeutic Advances in Medical Oncology|December 1, 2011
Future directions in the evaluation of c-MET-driven malignanciesJohann S de Bono, Timothy A Yap
Trends in Molecular Medicine|April 3, 2002
The ErbB receptor family: a therapeutic target for cancerJohann S de Bono, Eric K Rowinsky
Molecular Cancer Therapeutics|May 6, 2010
Targeting the HGF/c-Met axis: state of playTimothy A Yap, Johann S de Bono
European Urology|April 8, 2019
PARP Inhibitors for Advanced Prostate Cancer: Validating Predictive BiomarkersJoaquin Mateo, Suzanne Carreira, Johann S de Bono
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathwayGerhardt Attard, Juliet Richards, Johann S de Bono
Pageof 50